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A B S T R A C T   
The novel coronavirus pandemic has rapidly spread around the world since December 2019. Various techniques 
have been applied in identification of SARS-CoV-2 or COVID-19 infection including computed tomography 
imaging, whole genome sequencing, and molecular methods such as reverse transcription polymerase chain 
reaction (RT-PCR). This review article discusses the diagnostic methods currently being deployed for the SARS- 
CoV-2 identification including optical biosensors and point-of-care diagnostics that are on the horizon. These 
innovative technologies may provide a more accurate, sensitive and rapid diagnosis of SARS-CoV-2 to manage 
the present novel coronavirus outbreak, and could be beneficial in preventing any future epidemics. Further-
more, the use of green synthesized nanomaterials in the optical biosensor devices could leads to sustainable and 
environmentally-friendly approaches for addressing this crisis.   
1. Introduction 
The sudden appearance of the novel coronavirus (SARS-CoV-2) in 
Wuhan, China, in December 2019, was the third type of coronavirus to 
cause serious infections in humans. It has had unprecedented adverse 
effects, not only on the healthcare services, but also on the world 
economy (Udugama et al., 2020). Earlier, acute respiratory syndrome 
coronavirus (SARS-CoV) was identified in Asia in 2003, and an outbreak 
of Middle East Respiratory Syndrome (MERS-CoV) in Saudi Arabia in 
2012 (Wang and Anderson, 2019; Ksiazek et al., 2003). Until now, 
despite the decline in the newly diagnosed patients in many countries, 
the World Health Organization (WHO) has warned that the spread of the 
SARS-COV-2 still has “growth potential”. As of 1st Sep.2020, more than 
60 million people have been infected with COVID-19 worldwide with 
more than more than 1⋅4 million deaths as of November 2020 (Bhas-
karan et al., 2021). Therefore, it is necessary to expeditiously develop 
new accurate diagnostic methods with high sensitivity to reduce the 
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mortality rate (Cheng et al., 2020). Lung computed tomography (CT) is 
used as an initial diagnostic procedure in individuals with suspected 
SARS-CoV-2, however, this technique can solely make possible to assess 
the patient’s lungs, but cannot easily be applied to monitor the results of 
therapy (Ai et al., 2020; Çinkooğlu et al., 2020). Molecular techniques 
such as reverse transcription polymerase chain reaction (RT-PCR) are 
employed to detect the genetic material of the virus in patients with 
symptoms of active infection. PCR testing can confirm the diagnosis of 
coronavirus when two specific SARS-CoV-2 genes have been identified. 
If only one of these genes is detected, the diagnosis is uncertain (Li et al., 
2020a; Corman et al., 2020). PCR tests may produce false-negative re-
sults that fail to identify the presence of SARS-COV-2 (Wikramaratna 
et al., 2020), which may be due to human error or problems with the test 
procedure itself. 
In order to protect vulnerable individuals, it is essential to rapidly 
establish the infection status of patients with SARS-COV-2, as well as for 
the hospital and emergency personnel. The current RT-PCR test requires 
several steps and needs several hours for sampling and the evaluation 
(Wikramaratna et al., 2020). On the other hand, the need for patients to 
attend hospitals and clinics to provide samples, itself increases the risk of 
contracting the SARS-COV-2. Therefore, more research is needed to 
improve diagnostic methods to reduce the mortality by providing more 
accurate and faster point-of-care (POC) diagnosis, and which could be 
produced on a commercial scale. So far, several rapid POC tests have 
been commercialized or developed to diagnose SARS-CoV-2 (Vashist, 
2020; Lassaunière et al., 2020). Evaluation of an antibody 
IgG/IgM-based POC rapid test showed only low sensitivity (36.4%) 
(Döhla et al., 2020). Therefore, due to the need for higher sensitivity and 
a rapid diagnosis, antigen-based systems or optical nanosensors could be 
deployed as a fast and safe method for detection of SARS-CoV-2. 
Optical biosensors can be categorized into different types, such as 
surface plasmon resonance (SPR), surface enhanced Raman spectros-
copy (SERS), or chemiluminescence (Pirzada and Altintas, 2020). LSPR 
and SERS-based optical biosensors are suggested for POC detection 
systems due to their high diagnostic sensitivity and ability to be 
commercialized (Sun et al., 2020; Granger et al., 2016). 
Metallic Nanoparticles (NPs) are widely applied in biomedical field 
because their large surface lets the guest molecules such as drugs to get 
absorbed, entraped, or bind within the surface of the particles. Metallic 
NPs, such as Au, Ti, Fe, Se, and Metal Oxide NPs, namely zinc oxide 
(ZnO), iron oxide (Fe2O3/Fe3O4), titanium oxide (TiO2) etc. have 
attracted great interests as potential in drug/gene delivery and bio-
sensors due to importance applications in the domain of clinical and 
therapy. Green synthesis of metallic and metal oxide NPs using different 
greener reducing agents can provide an eco-friendly conditions for 
biomedical applications especially in the biosensors. Recently, several 
studies have been performed on the greener synthesis of metallic and 
metal oxide NPs with different limit of detection and abilities to transfer 
the drug/gene to the targeted cell that showed excellent biocompati-
bility without any toxicity in vitro tests. 
Herein, the current serological and molecular techniques for the 
detection of SARS-CoV-2 are discussed, and the emerging diagnostic 
systems based on optical biosensors and POC testing are summarized; 
the techniques discussed being shown in Fig. 1. Furthermore, in this 
review, a novel approach based on the use of green synthesized nano-
materials for the early diagnosis and detection of SARS-CoV-2 has been 
discussed in-depth. 
2. Characteristics of the SARS-CoV-2 genome and antigenic 
proteins 
Coronavirus are enveloped viruses, belonging to the Coronaviridae 
family, which are divided into four genera, α, β, γ, and δ; SARS-CoV-2 
belongs to the β genus (Yang and Wang, 2020). Transmission electron 
microscopy (TEM) of human airway epithelial cells isolated from a 
coronavirus patient in Wuhan, China, showed that the virus particles 
were 60 to 140 nm in diameter and had distinctive spikes of 9 to 12 nm 
(Zhu et al., 2020). SARS-CoV-2 is a positive sense RNA strand of ~30, 
000 nucleotides, and contains about 6–11 open reading frames (ORFs) 
(Guo et al., 2020). 
ORF 2–10 encode four essential structural proteins, including the 
nucleocapsid (N), spike (S) glycoprotein, matrix protein, and envelope 
(E) protein (Ujike and Taguchi, 2015). The N protein is responsible for 
packaging the RNA genome, while the E protein enables assembly of the 
virus, and is important for the pathogenesis. The S protein, for the 
interaction of the virus with cellular membrane, binds to the 
angiotensin-converting enzyme 2 (ACE2) receptor on the surface of 
human cells. Glycoprotein S consists of two subunits, S1 and S2; S1 
Abbreviation 
4-aminothiophenol (4-ATP) 
Acute respiratory syndrome coronavirus (SARS-CoV) 
Alpha-fetoprotein (AFP) 
Angiotensin-converting enzyme 2 (ACE2) 
Clustered regularly interspaced short palindromic repeats (CRISPR) 
DNA endonuclease-targeted CRISPR trans-reporter (DETECTR) 
Double stranded DNA (dsDNA) 
emergency use authorization (EUA) 
Enzyme-linked immunosorbent assay (ELISA) 
Food and drug administration (FDA) 
Gold NPs (AuNPs) 
Gold superparticle (GSP) 
Hemagglutinin (HA) 
Heptad repeats (HR) 
Horseradish peroxidase (HRP) 
Lateral flow immunoassay (LFIA) 
Limit of detection (LOD) 
Localized surface plasmon resonance (LSPR) 
Loop-mediated isothermal amplification (LAMP) 
Lung computed tomography (CT) 
Middle East Respiratory Syndrome (MERS-CoV) 
Multicomponent reactions (MCRs) 
Nanoparticles (NPs) 
Neuraminidase (NA) 
Open reading frames (ORFs) 
Plasmonic photothermal therapy (PPT) 
Point-of-care (POC) 
Poly-dimethyl sulfoxide (PDMS) 
Polyethylene glycol (PEG) 
Poly-methyl-methacrylate (PMMA) 
Quantitative real-time PCR (RT-qPCR) 
Quantum dots (QDs) 
Receptor-binding domain (RBD) 
Recombinant polymerase amplification (RPA) 
Reverse transcription polymerase chain reaction (RT-PCR) 
Specific High-sensitivity Enzymatic Reporter Unlocking 
(SHERLOCK) 
Surface enhanced Raman spectroscopy (SERS) 
Surface plasmon resonance (SPR) 
Transmission electron microscopy (TEM) 
Volatile organic compounds (VOCs) 
World Health Organization (WHO) 
Zirconium quantum dots (ZrQDs)  
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regulates the tropism of the virus to host cells with its receptor-binding 
domain (RBD), while S2 facilitates virus-cell membrane fusion via the 
heptad repeats 1 (HR1) and HR2 domain (Guo et al., 2020). 
The analysis of the spike protein showed the presence of NH2…..S- 
Cys-G-S-Cys-Cys-K-COOH sequence, with disulfide bonds between 
cysteine amino-acids (C323, C366, C467, etc.) (Li et al., 2005). Tar-
geting these disulfide bonds could be an option for designing optical 
sensors for the detection of SARS-CoV-2. 
The subunits of SARS-CoV-2 and SARS-CoV showed 88% similarity 
in sequence, and their binding to the ACE2 receptor is largely similar 
(Walls et al., 2020). However, the RBD domain in the S protein is the 
most variable part of the viral genome. Some amino-acids in human 
SARS-CoV-2 (such as, F486, L455, Q493, Y505, etc.) are known to play 
an important role in binding to ACE2 receptors, as well as in determining 
the host range of the viruses (Ou et al., 2020; Andersen et al., 2020). 
These amino-acids are different between SARS-CoV-2 and SARS-CoV, 
and also in different virus species that infect specific hosts (Fig. 2) 
(Andersen et al., 2020). Since cross-species diagnosis of the virus could 
play a significant role in reducing its spread, this feature could be taken 
into account in the design of specific biosensors. 
Fig. 1. Schematics for the current Lung computed tomography (CT), molecular assays for detection of COVID-19, and emerging diagnostics assays based on optical 
–based biosensor and POC testing. 
Fig. 2. Schematic illustration of four structures of antigenic proteins of coronavirus, nucleic acid and protein sequence of SARS-CoV-2 spike protein (red area), and 
main residues in the spike protein that bonding to the ACE2 receptor (blue area) (Andersen et al., 2020). (For interpretation of the references to color in this figure 
legend, the reader is referred to the Web version of this article.) 
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3. Current routine diagnostic methods for detection of SARS- 
CoV-2: molecular and immunoassay based-techniques 
There is a consensus that it may take between 1- 2 weeks from the 
time the person becomes infected to the onset of symptoms. During this 
time an individual has the opportunity to infect other people (Qin et al., 
2020). We also need to consider the time required to perform the test 
and the individual to receive the results. In all countries of the world, 
testing is important for the early diagnosis of COVID-19 and the im-
mediate isolation of patients diagnosed with the virus, and efforts are 
being made to develop diagnostic kits and methods with high-sensitivity 
and specificity. So far, several molecular and serological methods and 
diagnostic kits have been reported for the detection of COVID-19. 
3.1. RT-PCR-based techniques 
After the RNA sequence was determined by whole genome 
sequencing carried out in China in December 2019, the first diagnostic 
SARS-CoV-2 kit was developed in Berlin based on RT-PCR which can 
detect the coronavirus RNA in the first week of infection. This test is 
based on specific probes and is used only for the detection of RNA of the 
SARS-CoV-2 virus based on specific genes such as S, E, N and RdRP genes 
(Corman et al., 2020). Since viral samples are small and can contain a 
viral load of only a few particles, false-negative test results and low 
sensitivity are distinct possibility. The sensitivity of chest CT (98%) was 
found to be higher than the RT-PCR (71%) in patients at Taizhou Enze 
Medical Center, China (Fang et al., 2020). 
Following the epidemic of SARS-CoV-2, many companies have 
developed quantitative real-time PCR (RT-qPCR) detection kits for the 
clinical diagnosis of virus around the globe. These experiments were 
performed based on specific primers for the ORF1ab/RdRp, S, N, and E 
sequences (Li et al., 2020a). Corman et al. developed RT-qPCR assays 
based on TaqMan fluorescence signal for the detection of the ORF1ab 
and N regions of the virus with a sensitivity of below 10 copies/reaction 
in 1 h and 15 min, respectively (Corman et al., 2020). Up to now, 
different RT-PCR SARS-CoV-2 testing kits are accessible commercially of 
which 29 kits have been approved by United States Food and Drug 
Administration (FDA) (Garg et al., 2020). Kasteren et al. compared 
seven commercially available RT-PCR testing kits from varius com-
panies and showed ≥96% efficiency for the detection of low concen-
trations of SARS-CoV-2 RNA (Limit of detection (LOD) of 3.8–23 
copies/mL) in clinical samples with 100% specificity. They described 
that all seven commercial RT-PCR kits could be used for the routine 
detection of COVID-19 through diagnostic laboratories (Van Kasteren 
et al., 2020). The sensitivity and LOD of six approved RT-PCR SAR-
S-CoV-2 testing kits was investigated by Wang et al. High sensitivity and 
LoDs of 484 copies/mL was shown for four kits such as Liferiver Biotech, 
BGI Genomics, SanSure and DAAN and the LoD of BioGerm kit was 968 
copies/mL. However, they showed the LOD of 7744 copies/mL for 
GeneoDx kit that displayed lowly sensitivity, which can be attributed to 
the technical deficiencies in the product’s design (Wang et al., 2020). An 
overview of the some available RT-PCR SARS-CoV-2 testing kits and 
their properties is presented in Table 1. 
RT-qPCR techniques generally display high specificity and sensitivity 
in the detection of SARS-CoV, but these approaches are not without 
limitations. In five patients, whose RT-qPCR test results were negative 
for SARS-CoV-2, chest CT scans showed positive results and eventually 
these 5 patients were found to be infected with the COVID-19 (Xie et al., 
2020). Other disadvantages of this technique is its time-consuming na-
ture, needs for special instruments, highly technical operation and a 
possible long waiting time for results (Li et al., 2020a). 
3.2. LAMP-based techniques 
The loop-mediated isothermal amplification (LAMP) technique is a 
unique nucleic acid amplification method that amplifies reverse- 
transcribed DNA in a short time, with high specificity under 
isothermal conditions. In addition, this technique also can be visual, 
there is no need special instruments, and a constant temperature metal 
bath is enough. In this method, a DNA polymerase and set of four-six 
specific primers, amplify target genes up to 109 copies (Nagamine 
et al., 2002; Nguyen et al., 2020). The LAMP method is more sensitive 
than conventional PCR technique, and although it is less sensitive 
compared to qPCR it is faster than the other assays evaluated. In spite of 
the low sensitivity, the LAMP method showed increased specificity 
compared to other techniques such as qPCR as a one-step detection 
method (Khan et al., 2018; F Zhang et al., 2020a). Yan et al. described a 
reverse transcription LAMP (RT-LAMP) method tested in 130 patients, 
that was simple, rapid, with specificity and sensitivity of 2 × 101 and 2 
× 102 copies/reaction using orf1ab-4 and S-123 primers. The mean time 
for this method was 26.28 ± 4.48 min, and it could detect the virus in 
suspicious and high-risk individuals. This method was much faster and 
simpler than RT-PCR and did not need any complex equipment (Yan 
et al., 2020). Since time and simplicity is crucial in the diagnosis of 
epidemic diseases, the LAMP technique could be a good option for the 
POC applications. 
POC tests are used to rapidly and accurately diagnose patients 
without any need to send clinical samples to medical laboratories, and 
precludes the need for advanced laboratory equipment (Kozel and 
Burnham-Marusich, 2017). Nucleic acid extraction, amplification and 
detection can be combined into one integrated cartridge in POC devices, 
which will provide rapid, simple, and safe results. LAMP and lateral flow 
immunoassay (LFIA) could be useful in POC devices to detect COVID-19. 
The high sensitivity and rapid performance of the LAMP technique 
makes it a good choice for POC devices (Kozel and Burnham-Marusich, 
2017; Vashist, 2020). 
In February 2020, Professor Jinzhao Song and colleagues at the 
University of Pennsylvania described a simple POC closed-tube molec-
ular test for COVID-19 that could be performed easily and rapidly in a 
clinic without any need for expensive equipment. In fact, this device 
combined paper and LAMP measurement technology and could be used 
for the sensitive and rapid detection of COVID-19. This experiment was 
based on closed-tube Penn-RAMP, a two-stage isothermal double 
stranded DNA (dsDNA) amplification technology that used recombinant 
polymerase amplification (RPA) in a single tube. In this study, first 
complete genome sequences of various COVID-19 isolates were aligned, 
and the conserved sequences with the highest homology to the target 
sequence were selected to design the primers. Due to the lack of access to 
authentic COVID-19 samples, inactivated HIV virus particles and other 
pathogens from the nasal mucosa were used to establish the test. The 
Table 1 
Overview of RT-PCR –based kits in order to detection of SARS-COV-2.  
Manufacturer/Kit Genes Sensitivity Specitivity Detection Time Limit of Detection (LOD) 
CerTest Biotec/VIASURE SARS-CoV-2 Real Time PCR Detection 
Kit 
ORF1ab, N up to 97.5% 100% 120 min 2000 copies/mL 
Seegene/The Allplex 2019-nCoV RdRp, N, E Up to 90.0% 100% Results within 2 h after extraction 100 copies/mL 
KH Medical/RADI COVID-19 Kit RdRp, S 100% 100% 80 min 0.66 copies/μL 
Liferiver/2019-nCoV realtime multiplex RT-PCR ORF1ab, N, E High High Short time 1 × 103 copies/mL 
BGI/Real-time Fluorescent RT-PCR Kit ORF1ab 94.3% 100% 3 h 100 copies/mL 
Altona Diagnostics/RealStar® SARS-CoV-2 RT-PCR Kit E, S Up to 97% 100% – 3.8 copies/mL  
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samples were added to a tube for amplification, and LAMP was per-
formed at 63 ̊C, and then the Penn-RAMP process was carried out at 38 ̊C 
and 63 ̊C. Penn-RAMP alone is highly sensitive compared to LAMP and 
RT-PCR alone, as well as 100 times more sensitive than a single LAMP 
test. The Penn-RAMP method has other advantages; in addition to being 
easy to perform, it does not have a high cost and can be performed in 
both clinical and home settings. However, when the LAMP technique is 
used alone, it requires complex equipment and a constant temperature 
(Mohamed et al., 2020). 
However, molecular techniques are not without their problems, and 
require a complicated setup with multiple primers, which might be 
difficult in some settings, and false positive results can occur due to the 
use of non-specific dyes (Vijay J. Gadkar et al., 2018). 
3.3. Immunoassay-based techniques 
Several immunoassay methods have been developed to detect 
COVID-19 virus proteins or to detect serum antibodies. Most commercial 
immunoassay kits are based on detecting IgM or IgG antibodies pro-
duced a few days to two weeks after the onset of viral infection (Laing 
et al., 2016; Amanat et al., 2020). Amanat et al. developed an 
enzyme-linked immunosorbent assay (ELISA) test for specific and sen-
sitive detection of SARS-COV-2 at 3 days post-symptom onset which was 
performed using recombinant antigenic proteins of SARS-CoV-2 and 
detected seroconversion in human serum and plasma (Amanat et al., 
2020). There are many commercial companies in the field of COVID 
immunoassays and rapid IgM/IgG tests for the rapid detection of 
SARS-CoV-2, including Jiangsu Medomics Medical Technology, Bio-
merica, Orient Gen, Sugentech Biotech, Nanjing, China (Li et al., 2020b; 
Amanat et al., 2020; Vashist, 2020). Because the production of IgM and 
IgG occurs two weeks after the onset of infection, depending on the age 
and sex of the individual, and the severity of the disease, other bio-
markers and diagnostic methods are required for the rapid diagnosis of 
SARS-CoV-2. Antibody-based diagnostic tests can also distinguish be-
tween other causes of infection, including different coronaviruses (Zhao 
et al., 2020a). 
LFIA is a user-friendly assay format that does not require technical 
expertise, and can provide a low-cost POC approach for SARS-CoV-2 
detection. The lateral flow assay uses a paper or nitrocellulose mem-
brane strip, which is coated with metallic NPs (AuNP)-conjugated An-
tibodies to capture viral proteins in the serum. After adding the patient 
sample (blood, plasma, or serum) to the membrane, viral proteins are 
drawn across the strip. As the virus antigens react with the colloidal gold 
NPs (AuNPs) -Antibodies in the first line, the complex formed is captured 
on the strip by IgG and IgM antibody within seconds, and the color of Au 
NPs change from red to blue because of the plasmon band coupling after 
aggregation. The results of the test can be read in 10–15 min. Although 
many companies around the world are developing rapid serological 
tests, one of the major problems is the cross-reaction between anti-
bodies, which could have a false positive result to other coronaviruses 
types, and the loss of antibody. As a result, the accuracy of these tests 
should be determined by further testing (Tomás et al., 2019; Zhao et al., 
2020a). 
Researchers are currently studying other diagnostic techniques, 
including chip-based testing, microfluidics, and nanotechnology-based 
biosensors for the simple and rapid detection of SARS-CoV-2, as well 
as developing fully automated in vitro POC diagnosis methods that can 
perform both, the molecular and immunological tests on a single 
analytical platform. 
Table 2 lists the currently deployed diagnostic techniques with the 
times, advantages and disadvantages for the detection of SARS-CoV-2. 
3.4. CRISPR technology 
The discovery of clustered regularly interspaced short palindromic 
repeats (CRISPR) was a important step forward in gene editing and 
diagnostic applications. CRISPR is a type of adaptive immunity applied 
through bacteria to protect themselves against infection with bacterio-
phages (Chertow, 2018). Among different diagnostic techniques, the 
CRISPR/Cas system is being studied for specific and rapid diagnosis of 
SARS-COV-2. 
In recent years, researchers have developed a high specific and 
sensitive detection technology named Specific High-sensitivity Enzy-
matic Reporter Unlocking (SHERLOCK), which uses the activity of the 
crRNA/Cas13a protein complex to detection DNA and RNA molecules 
through amplification of the nucleic acid by an LAMP reaction, then 
detection of the products using CRISPR mediated reporter unlocking 
(Joung et al., 2020). The SHERLOCK system based on CRISPR/Cas13 has 
been applied to POC detection of SARS-CoV-2 by Zhang et al. who 
applied two crRNAs that diagnose two gene of COVID-19 such as 
ORF1ab and S gene in a range 10–100 copies/μL within 1 h (Zhang et al., 
2020b). Recently, researcher showed that the DNA 
endonuclease-targeted CRISPR trans-reporter (DETECTR), as an inex-
pensive, visual and fast test could detect SARS-CoV-2 in <40 min 
through applying a lateral flow strip depend on a CRISPR system. This 
assay is based on E, N, and RNase P genes and includes three steps such 
as LAMP reaction at 62 ◦C for 30 min, Cas12 detection reaction at 37 ◦C, 
which takes 10 min, and RT lateral flow which takes approximately 2 
min. The LOD of this assay being 10 copies/μL (Broughton et al., 2020). 
Another study also indicated that a CRISPR/Cas13-based assay could be 
Table 2 
Advantages and disadvantages of current techniques in detection of SARS-CoV-2.  
Tests Analysis of 
Time 






Sequencing of fully genome Need an expensive equipment Soon et al. (2013) 
RT-PCR About of 
1–1.5 h 
Good specificity False-negative test results, lower sensitivity than 
CT scan in some patients, need a complex 
equipment 
(Corman et al., 2020;  
Wikramaratna et al., 
2020) 
RT-qPCR About of 
1–1.5 h 
Highly sensitive technique for the detection and 
quantification of specific nucleic acids 
Time-consuming, False-negative test results Li et al. (2020a) 
LAMP About 
30min 
LAMP is quick and does not need costly reagents or 
appliance, cost-effective and high specificity. high 
specificity, efficiency, and rapidity, diagnostic sensitivity 
>95%. 
Primer design is complex, unable to perform 
multiplex amplification, need a non-specific 
dyes and false positive results 
(Khan et al., 2018; Vijay 
J. Gadkar et al., 2018) 
ELISA About 2 h 
with kit 
High sensitivity (20–80%) Antibody instability, high cost to synthesis 
antibody, IgG and IgM production takes place 
two weeks after the onset of infection 
(Zhao et al., 2020a;  






Rapid detection assay with 97% sensitivity Low specific Ai et al. (2020)  
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applied to destroy SARS-CoV-2 sequences in human lung epithelial cells, 
killing more than 90% of coronavirus (Abbott et al., 2020). 
3.5. Commercial POC-based molecular and immunoassay techniques for 
the diagnosis of SARS-CoV-2 
At present many companies are trying to develop and commercialize 
POC in vitro diagnostic systems for the early diagnosis and control of 
COVID-19. The FDA has issued emergency use authorization (EUA) for 
20 different SARS-CoV-2 tests, including those from Chembio, Abbott, 
BioMedomics, etc. A list of some POC devices for COVID-19 that have 
been, or are in the process of being commercialized, is provided in 
Table 3. 
The COVID-19 IgM/IgG Rapid Test system was one of the first rapid 
POC LIFA systems for the diagnosis of COVID-19 developed by Bio-
Medomics Co., USA, NC. This system is capable of rapid results in 10–15 
min and is based on IgG and IgM antibodies present in plasma serum and 
blood samples. Requiring only a very small sample (20 μL of finger blood 
or 10 μg of serum/plasma), this test may be used anywhere Although the 
sensitivity of this diagnostic test is 88.66%, tests like LAMP have a 
higher sensitivity, consequently, this system could be combined with 
techniques such as LAMP to develop POC systems with greater sensi-
tivity for COVID-19 detection (Sakamoto et al., 2018; Carter et al., 
2020). 
The Abbott ID NOW ™ test is one of the newest POC tests for COVID- 
19 detection that can give results within 5 min (positive results in 5 min 
and negative ones in 13 min). This test is based on the portable NOW 
platform using isothermal nucleic acid amplification technology and 
targeting the RdRp Gene. Given its small size, this system may be used 
anywhere, such as clinics and doctor’s offices, with nasal, pharyngeal, or 
oral samples (Vashist, 2020; Rao et al., 2017). It is hoped that the 
development of more rapid commercial POC systems will help identify 
the virus and control its spread in many countries. 
4. Optical-based nanosensors for rapid and sensitive detection 
of SARS-CoV-2 
Although RT-PCR and the chest-CT scan provide highly specific and 
sensitive detection of COVID-19, they are not suitable for POC devices, 
due to the need for the expensive equipment, the requirement for travel 
to the testing centers, and for hospitals to transfer virus contaminated 
samples. 
Nanotechnology is being used in the development of highly- 
sensitive, accurate, and efficient sensors to eliminate the need for 
trained staff in identifying viruses and other nanoscale pathogens 
(20–900 nm). Due to the unique properties of NPs, such as large surface 
area to volume ratio, and the presence of many reactive sites, nano-
materials can be efficient, more sensitive, and accurate for virus detec-
tion. The integration of nanosensors with other diagnostic methods 
provides more versatile diagnostic systems for the detection of high-risk 
pathogens both in and out of the laboratory (e.g., POC detection) 
(Quesada-González and Merkoçi, 2018; Hamdy et al., 2018; Ghasemi 
et al., 2018). Consequently, nanosystems have several advantages in the 
diagnosis of infectious disease. Because early and highly sensitive 
diagnosis is important in disease prevention and timely treatment, 
research advances in nanotechnology have been applied to virus 
detection. Optical biosensors can be used as a simple, safe and rapid 
method for early detection of epidemic viruses such as COVID-19, and 
can be deployed using various types of spectrometric readout, such as 
fluorescence, absorption, or SERS. Among all of these sensors, localized 
surface plasmon resonance (LSPR) and SERS display real potential as a 
sensitive optical sensor for virus detection, and have the most promise as 
POC detection systems, because they are label-free, operate in real time 
and have high sensitivity (Lee et al., 2017; Tokel et al., 2014). 
4.1. SERS–based nanosensors 
In recent years, many groups have investigated the application of 
biosensors for the accurate and highly-sensitive detection of various 
biomarkers, and also viruses such as the coronavirus family and influ-
enza virus (Kaya et al., 2020; Nikaeen et al., 2020). In the following 
section, some nanosensors that are based on optical signal detection 
strategies, and their role in the rapid and sensitive detection of the novel 
coronavirus (COVID-19), are discussed. One point of view suggests that 
the optimum detection and destruction of nanoscale viruses requires the 
use of nanoscale materials such as NPs. 
SERS has gained considerable interest as a potential strategy for the 
diagnosis at a molecular level due to its non-invasive nature, combined 
with high sensitivity and specificity. In the SERS technique, after the 
analyte molecule is absorbed onto a SERS substrate, the Raman signal of 
the molecule is dramatically increased due to the plasmon resonance at 
the surface of a gold nanostructure. Unlike fluorescence, which shows 
broad bands, the spectral band-width of Raman signals are narrow. This 
high resolution of the peaks in SERS spectra allows simultaneous 
detection of multiple molecules in the same sample. Other benefits of 
SERS are its rapid analysis rate, simplicity of sample management, and 
the ability to produce commercial devices. However, SERS has some 
limitations, namely the degradation of the substrate over time leading to 
a reduction in the signal intensity (Mosier-Boss, 2017; Laing et al., 
2016). 
For nucleic acid-based techniques such as RT-PCR the first step in-
volves the extraction of high quality DNA or RNA which reduces false 
negative results. The use of poly(aminoester) carboxyl-(PC)-coated 
magnetic NPs (pcMNPs) for RNA extraction, provides an automated, 
simple extraction method taking only 20 min, and reducing the amount 
of contamination during extraction, as well as combining the lysis/ 
binding processes into a single step. The MNP-RNA complex can be used 
directly in the RT-PCR technique without any elution step, making it 
Table 3 
The list of current COVID-19 POC test producing by different companies.  
Companies Product Time Method Approved 
Status 
Abbott ID ID now TM 
COVID-19 






























45 min Real-time RT-PCR FDA 







Fluxergy LLC Fluxergy 
Analyzer 
system 







The first FDA-approved POC system was developed by Cepheid (Cepheid Gen-
eXpert® Systems) for the rapid molecular detection of SARS-CoV-2 which could 
provide results within 45 min and is based on real-time RT-PCR. It is used for 
qualitative detection of SARS-CoV-2 nucleic acids in a nasopharyngeal swab or 
nasal wash from individuals suspected of being infected with COVID-19. The 
system employs disposable cartridges containing the RT-PCR reagents and 
acting as a platform for the RT-PCR process. The risk of contamination between 
samples is reduced due to its use of self-contained cartridges. The test costs 
between $10-$20 per sample (Vashist, 2020; Soon et al., 2013). 
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faster and easier for COVID-19 diagnosis. In addition, the use of this 
complex in SERS-based RNA detection could be useful in high-sensitivity 
home diagnosis (Zhao et al., 2020b). 
Metal organic frameworks (MOF) represent a class of polymers 
consisting of metal ions or clusters coordinated to organic ligands to 
produce one, two, or three-dimensional structures. MOF have been 
investigated for SERS due to their unique structure and chemical and 
thermal stability. MOF can serve as solid-phase extraction materials 
with the ability for rapid concentration and size-selectivity (Lai et al., 
2020). Hundreds to thousands of different MOFs could be included in a 
library of porous materials for different biological applications (Maurin 
et al., 2017). The effects of morphology, size and optical properties of 
metal NPs such as gold and silver have been explored with the goal of 
optimizing SERS substrates. AuNPs (1–200 nm) have been widely 
applied in the field of virus detection due to their unique optical/elec-
trical properties. Surface plasmon oscillations in AuNPs can increase 
Raman scattering upon optical excitation (Ou et al., 2019; Qiao et al., 
2018). The examination of gas and liquid phase biomarkers in exhaled 
breath and coughs could detect respiratory viruses, such as influenza 
and coronavirus as a non-invasive strategy for rapid diagnosis using the 
SERS method (Leung et al., 2020). As shown in Fig. 3A, the 
self-assembled AuNPs formed a “gold superparticle” (GSP) structure 
with approximately 170 nm diameter. In order to increase the adsorp-
tion of gaseous or liquid molecules, a ZIF-8 metal-organic-framework 
layer was coated onto GSPs. These MOFs lowered the electromagnetic 
field around the GSP surface, and with a reduced gas flow rate, they 
provided sufficient time for the adsorption of volatile organic com-
pounds (VOCs) that could serve as lung cancer biomarkers onto the SERS 
substrate. Reactions that formed a Schiff base between the amine groups 
of Raman-active 4-aminothiophenol (4-ATP) molecules absorbed onto 
GSPs and the aldehyde groups present in analytes, allowed the detection 
of aldehyde-containing VOCs at the 10 ppb level (Fig. 3B and C). This 
SERS sensor showed the ability to detect cancer biomarker at early 
stages, and also had the ability to serve as a simple biosensor for early 
and highly sensitive detection of COVID-19 based on the structure of 
viral antigens and their interaction with the GSP/ZIF-8 substrate (Qiao 
et al., 2018). There is a great interest in using green synthesized NPs for 
this purpose, and in this case, by using the sustainable and green syn-
thesized nanomaterials/NPs, the limit of detection of the biosensor 
could increase substantially. 
In order to overcome some limitations of immunoassay techniques, 
the combination of an immunoassay with SERS nanotags could provide a 
stable POC system for the simultaneous detection of multiple viral an-
tigens in a blood sample within 30 min. SERS nanotags could be useful 
for detecting possible infection with multiple pathogens, particularly in 
regions of the world, which are highly susceptible to outbreaks of in-
fectious disease. SERS nanotags are based on a core of 60-nm AuNPs 
functioning as a reporter, surrounded by a silica shell. In fact, each re-
porter can serve as a unique fingerprint and provides identifiable SERS 
spectra with different antigens (Fig. 4 A, B). SERS nanotags are stable 
under varying environmental conditions and do not require a cold-chain 
for storage and transfer, while simplifying the assay and reducing 
Fig. 3. Schematic illustration of Au NPs assembled into GSPs, (A) GSP@ZIF-8 core-shell structure formation; (B) Detection of VOCs by SERS spectroscopy; (C) 
Interaction between gaseous aldehyde and covalent linkage with amines groups of Raman active 4-ATP molecule absorbed in GSPs substrate (Qiao et al., 2018). 
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analysis time by eliminating the sample preparation and washing steps 
(Sebba et al., 2018). 
4.2. LSPR-based nanosensors 
SPR and LSPR systems are promising for detecting various types of 
clinical analytes (Masson, 2017). In SPR, electrons are excited at the 
interface of a thin metal film and a dielectric medium. LSPR is an indi-
rect approach to enhance SPR sensitivity and can be applied to label-free 
sensing (Malekzad et al., 2018). Colorimetric detection using AuNPs was 
developed due to the effect of LSPR on the optical properties. AuNPs 
show a red color when they are dispersed, but when they become 
aggregated the color changes to blue with maximal absorbance at longer 
wavelength (Ahmadi et al., 2018). 
Colorimetric techniques based on AuNPs have been established for 
the rapid and simple detection of coronavirus family members in 10 min, 
and can entirely eliminate the need for instrumentation or skilled 
personnel. This nanosensor assay could accomplish the detection of 
MERS-CoV nucleic acids with a sensitivity limit of detection as low as 1 
pmol/μL. Therefore, it could be very useful for the early diagnosis of 
coronavirus, which is critical for such a contagious epidemic (Kim et al., 
2019). As shown in Fig. 5A, in absence of a target, disulfide bond for-
mation occurs between the thiolate-labeled probes. Thereafter, with the 
addition of salt, aggregation of Au NPs and a color change (from red to 
blue) can be observed along with LSPR peak changes. In the presence of 
a target, the thiolate probes react with the target to form a dsDNA 
structure, which binds to the surface of AuNPs through disulfide bonds, 
thus protecting the AuNPs from salt-induced aggregation and no color 
changes occurs (Fig. 5B). In fact, the very high sensitivity of AuNP-based 
colorimetric techniques for nucleic acid detection have stimulated the 
use of AuNPs for the sensitive detection of SARS-CoV-2, or in combi-
nation with other properties of AuNPs. 
Cysteine and methionine binds to AuNPs through their sulfhydryl 
(-SH) groups and can induce the aggregation of NPs via hydrogen bond 
formation or zwitterionic interactions. This allows the observation of 
color changes (from red to blue) with the naked eyes (Ahmadi et al., 
2018). Since, the amino acid cysteine is present in the sequence of the 
antigenic proteins of SARS CoV-2, when the virus is present in the gas 
Fig. 4. Schematic illustration of SERS nano tags (A); and different SERS spectra in presence of Ebola, Lassa, and malaria antigens (B); sandwich immunoassay, 
binding Antibodies - SERS nanotag to Antibodies - magnetic microparticle in presence of antigen (C) (Sebba et al., 2018). 
Fig. 5. Schematic illustration of colorimetric detection of MERS-CoV nucleic acids; (a) aggregation of Au NPs in the absence of targets by addition of salt; (b) 
preventing Au NPs aggregation by disulfide induced self-assembly in the presence of targets (Kim et al., 2019). 
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phase (exhaled breath, sneeze, cough) or in the solid phase (adhering to 
clothes, mask, or surfaces), it can be rapidly detected by using the optical 
properties of Au NPs. However, this method is not completely specific 
since cysteine amino acids may exist in other pathogen proteins, it could 
be useful in emergency detection leading to further RT-PCR testing. 
The likelihood that viruses (such as influenza and coronavirus) can 
be transmitted from animals to humans is an important issue. Because 
the transmission of viruses between different animal species and thence 
to humans is possible and even probable, the ability to differentiate 
between strains of human viruses and those of other animal species is of 
paramount importance in the present pandemic (Parrish et al., 2008; 
Bolles et al., 2011). Various strains of influenzas viruses can be detected 
using thiolate polyethylene glycol (PEG)-gold NPs (16 nm) functional-
ized with sialic acids containing carbohydrates (glyco-NPs). The influ-
enza virus contains two different types of surface glycoproteins, 
including neuraminidase (NA) and hemagglutinin (HA). Glyco-NPs that 
were functionalized with trivalent α2,6-thio-linked sialic acid and mixed 
with human influenza virus X31 (H3N2), generated a color change that 
could be observed in 30 min. HA binds to the residues of α-2,6 and α-2,3 
sialic acids in human and bird cells, respectively. The HA expressed by 
avian influenza virus binds specifically to α-2,3-sialic acid, which is 
preferentially expressed in the intestinal tract, while HA proteins from 
human-influenza viruses bind to α-2,6 sialic acid in the respiratory tract 
epithelial cells. As a result, based on differences in the sialic acid resi-
dues, this biosensor could distinguish between avian and human influ-
enza viruses between 0 to 3.0 μg/mL (Marín et al., 2013). The 
attachment of polyethylene glycol (PEG) chains can improve the sta-
bility of larger size AuNPs and increase the performance of nanosensors, 
because they prevent the nonspecific adsorption of peptides and proteins 
and increase the water solubility. In fact, glyco-AuNPs are a versatile 
hybrid nanosystem for diagnostic applications. In addition, the use of 
green synthesized AuNPs can effectively help to reduce the cost of the 
synthesis procedure, which significantly can help the early detection 
and treatment steps (Schulz et al., 2013; Compostella et al., 2017). 
The presence of multivalent functional groups on the surface of 
PEGylated NPs can play a key role in the highly selective binding to 
different strains of the virus. Nevertheless, heterogeneous mixtures of 
functional groups could increase the discriminatory ability of the 
biosensor (Otten et al., 2016). For example, trivalent α2, 6-thio-linked 
sialic acid specifically bound to H3N2 influenza virus and could distin-
guish between diverse strains of influenza. Thiol-linked sialic acids in 
heterogeneous mixtures could also differentiate between virus strains 
from different animal species. 
Otten et al. used heterogeneous mixtures of glycans on the surface of 
glyco-AuNPs to distinguish between members of a small panel of legume 
lectins in a green media (Otten et al., 2016). This approach may also be 
used in the specific detection and differentiation between SARS-CoV and 
SARS-CoV-2 viruses, and different types of coronavirus from animal 
species. The use of PEGylated-AuNPs as a biosensor to differentiate 
between the two amino acids cysteine and aspartic acid was described 
by Chen et al. Aspartic acid was added to a solution containing NPs 
bound to cysteine (by SH bonds) and bound via its amine and carboxyl 
groups. Moreover, this study showed that increasing the size of the NPs 
from 13 to 45 nm could lower the detection limit (from 18 μM to 1.8 nM) 
(Chen et al., 2018). 
SARS-CoV-2 virus binds to ACE2 receptors through specific amino 
acids in the S1 antigen protein (L455, F486, Q493, S494, N501, and 
Y505). Specific amino acids in human ACE2 (K31, E35, D38, M82, and 
K353) are able to form hydrogen bonds with the S1 protein (Luan et al., 
2020; Walls et al., 2020). Furthermore, additional binding may involve 
the carboxyl groups of the ACE2 receptor interacting with the carboxyl 
and amine groups of the S1 antigen. Based on these studies, it may be 
possible to specifically detect COVID-19 by designing different optical 
biosensors, including PEG-Au NPs, essentially based on specific binding 
between the amino acids (for instance D38 and S494). In addition, the 
use of heterogeneous mixtures of amino acids may allow better 
differentiation between viruses from different animal species. 
The tunability of the optical-thermal properties of plasmonic AuNPs, 
enables plasmonic photothermal therapy (PPT), where the wavelength 
of the laser can be matched with the enhanced absorption in the visible 
and NIR spectral regions due to the SPR oscillations (Huang et al., 2007; 
Qiu et al., 2020). An optical nanosensor combining the LSPR and pho-
tothermal effect was developed to discriminate between two similar 
SARS-CoV-2 gene sequences with high sensitivity (detection limit of 
0.22 pM). In this study, an Au film was coated with thiol-cDNA ligands 
and self-assembled into a nanostructured chip. In this sensor, in addition 
to plasmonic sensing, laser irradiation at a wavelength corresponding to 
the plasmonic resonance frequency led to substantial heat being 
generated on the AuNI chip. This PPT heat effect raised the hybridiza-
tion temperature and allowed the precise discrimination between two 
similar sequences. Fig. 6B shows the hybridization of a RdRp gene of 
SARS-CoV-2 with a complementary cDNA sequence. The photothermal 
effect could increase the hybridization kinetics between the two se-
quences, and the response-slope of LSPR with photothermal excitation 
was steeper than that without the photothermal excitation. Further-
more, this nanosensor was able to discriminate between two similar and 
non-complementary sequences by the photothermal effect (Fig. 6C) (Qiu 
et al., 2020). 
4.3. Fluorescence-based nanosensors 
Fluorescent biosensors have high sensitivity and selectivity, and a 
shorter response time usage in fields such as medical diagnostics. 
Fluorescence biosensors use fluorescent molecules as the signal output 
component. The specific detection is observed through changes in the 
fluorescence intensity or else by creation of fluorescence polarization 
(Wang et al., 2011; Jeong et al., 2018). 
Quantum dots (QDs) are colloidal NPs of semiconductor origin, 
which have become highly popular in the nanosensing and bio-imaging 
fields, due to their stable optical properties, broad range excitation 
wavelength and tunable narrow fluorescence emission (Zhu et al., 
2013). In comparison with organic fluorophores, QDs have size-tunable 
optical features (e.g. emission spectrum), and by adjusting their size, 
coating and attached ligands, can be tailored to detect various targets 
with high sensitivity for different samples (Han et al., 2001). 
Ahmed et al. (2018) developed a fluorescence-based optical diag-
nostic nanosensor using chiral zirconium quantum dots (ZrQDs) to 
detect coronavirus in samples from patients with bronchitis infections. 
These NPs could form a strong and stable bonding with antiviral anti-
bodies and allowed the highly sensitive detection of coronaviruses. The 
antibodies were conjugated with ZrQDs and magneto-plasmonic MNPs, 
and then after the addition of antibody-conjugated and the target 
virusMNPs, led to the formation of nanostructured 
magnetoplasmonic-fluorescent structures under the influence of an 
applied external magnetic field. This allowed the magnetic separation of 
the virus, and the photoluminescence intensity of the nanohybrids was 
used to measure the concentration. The low toxicity of these NPs, as well 
as their good binding with antiviral antibodies suggested that these NPs 
could be a promising nanosensor for the detection of new coronavirus 
species. With a diagnostic sensitivity that was 10 times higher than the 
ELISA technique (100 EID/50 μL for NPs versus 1000 EID/50μL for 
ELISA), these NPs could be useful in diagnosis of pandemic viruses 
(Ahmed et al., 2018). 
Although antibodies are often applied in sensing assays, the sensi-
tivity can be limited by nonspecific interactions between the antibody 
and the target. Antibodies are also sensitive to heat and require special 
reaction conditions that can limit their use (Dobson et al., 2016; Aka-
zawa-Ogawa et al., 2018). Aptamers are single-strand synthetic RNA, 
DNA, or peptide sequences that can be designed to specifically recognize 
targets by repeated selective enrichment procedures. Their advantages 
include sustainability, efficiency, and high flexibility in design, so they 
can be used in a wide variety of biological sensors (Ahmadi et al., 2019; 
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Maghsoudi et al., 2019). QDs could be coated with oligonucleotide 
aptamers (linking the aptamer amine group to the QD carboxyl group) 
that recognized the N protein of SARS-CoV virus. In this study, a Pro-
linker™ coated protein chip was used to immobilize a sample containing 
SARS-CoV N protein by its carboxyl groups. When the SARS N protein 
was present in the sample the binding of the QD-aptamer could be 
quantified by the fluorescent emission from the chip. The LOD was 0.1 
pg/mL for this biosensor, and thus it could also be tested for detection of 
SARS-CoV-2 (Roh and Jo, 2011). 
Some polyphenolic compounds, such as catechin gallate and gallo-
catechin gallate, have shown some inhibitory potential against SARS- 
CoV as shown in Fig. 7A and B. At a concentration of 0.05 μg/mL, gal-
locatechin gallate and catechin gallate showed more than 40% 
inhibition activity as measured by a biochip system (Roh, 2012). How-
ever, the mechanism of these compounds binding to the SARS-CoV N 
protein is still unclear. In this study, SARS-CoV spike proteins could be 
used instead of N protein, because the spike proteins are longer in 
length, and could provide a stronger bond by reducing the distance 
between the moieties (Song et al., 2019). 
The LSPR signal from plasmonic metal NPs such as AuNPs and AgNPs 
has been used to amplify the fluorescence intensity signal of QDs, 
leading to lower detection limits (Adegoke et al., 2020). This feature of 
AuNPs was used to increase the sensitivity of detection of the NS1 
protein of Zika virus using a QD-labeled antibody. The AuNPs acted as a 
signal amplifier and the QDs functioned as the fluorophore signal. When 
the target NS1 protein was present, the LSPR phenomenon of the AuNPs 
Fig. 6. (A) Schematic illustration of dual functional plasmonic photothermal sensor for detection of SARS-CoV-2; (B) hybridization of RdRp gene sequence with 
complementary cDNA sequence with or without the PPT effect; (C) Discrimination of two similar sequences using PPT effect (Qiu et al., 2020). 
Fig. 7. Schematic illustration of inhibitor screening of SARS-CoV N protein using QDs-RNA on prolinker™–coated biochip (Roh, 2012).  
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increased the intensity of the QD emission because the two particles 
were sufficiently close together (few nm), thus increasing the sensitivity. 
The results of this study showed high sensitivity and rapidity for the 
detection of Zika virus over a wide range of concentrations (10 fg/mL to 
1 ng/mL) and a LOD of 1.28 fg/mL with 10–10(7) RNA copies/mL 
(Takemura et al., 2019a). The simultaneous use of a mixture of AuNPs 
and AgNPs could be even more effective and reduce the LOD to 1.7 
copies/mL, Nevertheless, the cost of developing a POC diagnostic plat-
form using LSPR in low or middle-income countries may be a challenge 
(Adegoke et al., 2017). 
Microfluidic technology is an effective methodology in POC devices, 
wherein small volumes of liquid sample can circulate in micron-sized 
channels, allowing for the use of smaller quantities of samples and re-
agents. This miniaturization results in much faster detection systems 
than conventional techniques (Nasseri et al., 2018; Jung et al., 2015). 
Microfluidic PCR chips have been developed to detect pathogens and 
viruses, and if properly designed, can replace conventional techniques 
such as RT-PCR and reduce the costs associated with diagnostics (Ahr-
berg et al., 2016). Because the world has been so deeply impacted by the 
coronavirus, and developing countries have fewer resources, the cost of 
diagnosis is a significant factor to consider. When the rate of virus spread 
is high, the lack of cost-effective diagnostic tools can rapidly escalate the 
costs for health care systems. 
Microfluidic chips can be constructed from different materials, such 
as silicon/glass, polymers such as poly-dimethyl sulfoxide (PDMS) or 
poly-methyl-methacrylate (PMMA), and even from paper (Kaneda et al., 
2012; Nge et al., 2013; Soum et al., 2019). Xia et al. (2019) described a 
PDMS-ZnO nanorod microfluidics chip that was based on a smartphone 
for POC, rapid, low-cost and sensitive colorimetric detection of viruses 
in samples within 1.5 h (Higashi et al., 2019). The channels of these 
nanostructures were made up of PDMS, and the ZnO nanorods were 
embedded in the channel walls, which enhanced the capture of the virus 
and improved the detection sensitivity. Viral specific antibodies were 
attached to the microchannel surface, and after the virus had bound to 
the antibody, a second anti-virus antibody labeled with AuNPs attached 
to the virus. In this system, the binding of gold served as a signal 
amplifier to improve the detection limit. This system allowed rapid 
detection of the virus by the naked eye with a sensitivity of 2.7 × 104 EID 
50/μL. This nanostructured microfluidic chip with its 
smartphone-enabled plasmonic detector system could be low cost, 
user-friendly and highly sensitive for the detection of SARS-CoV-2 virus 
antigenic proteins. 
4.4. Chemiluminescence -based nanosensors 
Chemiluminescence refers to light emission from the excited state 
product of a chemical reaction, when it returns to the ground state. In 
fact, when an electron drops to a lower energy level from a excited or 
higher energy level, the energy is lost in the form of light, termed a 
chemiluminescent reaction (Christodouleas et al., 2011). In recent years, 
it has been found that chemiluminescence reactions can be catalyzed by 
metal NPs in immunoassays for antigen determination in assistance of 
using green media. This approach is not only sensitive and selective, but 
also simple, cost-effective and rapid (Zhou et al., 2016; Li et al., 2013). Li 
et al. developed a rapid, specific and sensitive detection technique for 
H1N1 influenza virus based on a chemiluminescence metalloimmuno-
assay using AgNPs as a label, with a LOD of 0.1 pg/mL. In this system, 
the binding of monoclonal antibodies onto polystyrene was initially 
carried out by physical adsorption. When HNO3 was added to the so-
lution, the silver salts were released into the solution and the chem-
iluminescence signal was produced by the Ag+–Na2S2O8 Mn2+–H3PO4 
luminol system (Li et al., 2013). 
MOFs can serve as labeling agents, due to their features such as good 
porosity, low toxicity, feasibility of modification on the outer surface, 
and pore modification through organic linkers (e.g. –COOH, –NH2, etc.). 
MOFs have a network structure with controlled chemical functionality, 
and the metallic centers of these particles allow their sensitive quanti-
fication by chemiluminescence approaches (Zhou et al., 2016; Miller 
et al., 2016). These properties make them ideally suited for detecting 
larger biomolecules, such as proteins, DNA, or RNA from pathogenic 
viruses. Zhou et al. (2016) reported a sensitive chemiluminescence 
metalloimmunoassay for the detection of alpha-fetoprotein (AFP), that 
used a metalloimmunoassay labelling agent such as MOF-NPs. MOF-NPs 
(Fe-MIL-88B–NH2) which was synthesized by a microwave-assisted 
procedure, with a size of 50 ± 5 nm in length and 30 ± 5 nm in 
width. The particles were bound to the secondary antibody through the 
carboxyl group of NH2-BDC and the amino group of the secondary AFP 
antibody. After the complete dissolution of the assay plate in hydro-
chloric acid and the release of Fe+3, the signal was detected by a 
flow-injection luminol-H2O2 chemiluminescence system (Zhou et al., 
2016) (Fig. 8). This system showed high sensitivity, low cost, good 
reproducibility, and was stable for long-term storage, even at room 
temperature. It was superior compared to systems that used other labels 
such as AgNPs or Fe3O4@Au (Riccò et al., 2018). This MOF-based 
chemiluminescence biosensor could be used for highly sensitive and 
low-cost detection of COVID-19. 
Table 4 lists some different optical nanosensors for the detection of 
various viral targets with high sensitivity. 
5. Routes for improvement 
5.1. Multicomponent reactions 
In recent decades, multicomponent reactions (MCRs) have gained 
much attention in the synthesis of drugs, heterocyclic compounds, li-
gands and biologically active molecules. In addition, this approach can 
effectively help the green chemistry and sustainable rules (Graebin 
et al., 2019; Shaabani and Hooshmand, 2018). MCRs have recently been 
applied to prepare functionalized nanomaterials, which are used as 
biosensors, nanocarriers for drug delivery, bioimaging reporters, anti-
bacterial materials and so on (Afshari and Shaabani, 2018). MCRs are 
single-step and one-pot reactions (most of them recently focused on 
green synthesized approaches by using water as the solvent) that include 
three or more commercially available or easily accessible starting ma-
terials, and which allow the construction of complex scaffolds. Nowa-
days, MCRs are becoming common within the synthetic organic 
chemistry community to increase the overall efficiency of synthetic re-
actions. One common type of MCRs, is isocyanide-based multicompo-
nent reactions (IMCRs) such as Ugi, Passerini and also the 
Groebke–Blackburn–Bienayme reactions (Alvim et al., 2014). The Ugi 
four-component reaction involves an amine, a carbonyl compound, a 
carboxylic acid, and an isocyanide all reacting together in a one-pot 
manner to form a pseudeopeptide-like framework is one of the most 
effective and practical examples (Yang et al., 2015). The use of MCRs 
enables chemists and biologists to design a biosensor that simulta-
neously contains different several bioreceptors, such as enzymes, 
aptamers and antibodies. MCRs have the advantages of being single-pot 
with short reaction times, and allowing diversity in the selection of 
substrates, for the development of cutting-edge biosensors (Fig. 9). 
Camacho and co-workers devised an innovative synthetic strategy 
for the construction of an alginate modified-gold electrode for immo-
bilizing horseradish peroxidase (HRP) enzyme using an Ugi four- 
component reaction (Camacho et al., 2007). In this procedure, the 
alginate-coated Au electrode was modified using the Ugi MCR method to 
produce a support for immobilizing the enzyme. Ultimately, the 
enzyme-modified Au electrode was a highly sensitive and rapid elec-
troanalytical biosensor for detection of H2O2. Another approach for the 
construction of biosensors based on the MCR strategy was developed by 
Vrbova and Marek, who used collagen as a natural material to fabricate 
an enzyme-catalyzed electrode for D-galactose determination. They 
immobilized galactose oxidase or co-immobilized galactose oxidase plus 
catalase to a Clark-type oxygen sensor using the Ugi-four component 
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Fig. 8. Schematic illustration of chemiluminescence metalloimmunoassay of AFP using MOFs NPs (Fe-MIL-88B–NH2 NPs) as labelling agent (Zhou et al., 2016).  
Table 4 
Selected examples of optical biosensor for viral diagnosis.  
Optical Biosensor Types of Types of sensors Virus/Sample Diagbostic Components Detection 
limit 
Ref 
SERS –based nano sensor Gold shell-isolated NPs 
(Au-SHINs) 
Zika virus anti-Zika NS1 antigens 10 ng/mL Camacho et al. 
(2018)  
Gold NPs Hepatitis B DNA sequence 0.1 fM Zengin et al. (2017)  
SERS nanotags Ebola, Lassa, and 
malaria 
Virus antigenes 5 × 105 PFU/ 
mL 
Sebba et al. (2018) 
SPR/LSPR-based nano sensor SPR chip Hepatitis B Surface antigen 0.00781 mg/L Tam et al. (2016)  
Gold NPs SARS-CoV-2 RdRp gene sequence 0.22 pM Qiu et al. (2020)  
Aptasensor Avian influenza virus 
H5N1 
Aptamer specific against H5N1 0.128 HAU Bai et al. (2012)  
CdSe–ZnS-based quantum 
dots 
Norovirus Virus particles 0.01 ng/mL Ashiba et al. (2017)  
Au/Ag sensing layers Human enterovirus 71 
(EV71) 
capsid protein VP1 67 vp/mL Prabowo et al. 
(2017)  
Gold NPs MERS-CoV Nucleic acid sequence 1 pmol/μL Kim et al. (2019) 
Fluorescent-based nano sensor Ag@SiO2 NPs H5N1 influenza virus Anti-recombinant hemagglutinin protein of 
H5N1 aptamer 
3.5 ng/mL Pang et al. (2014)  
Au/Fe3O4 and CdSeS QDs Norovirus Particles virus 0.48 pg/m Takemura et al. 
(2019b)  
QDs SARS-CoV SARS-CoV N protein 0.1 pg/mL Rao et al. (2017) 
Chemiluminescence -based nano 
sensor 
Ag NPs H1N1 influenza Virus antigenes 0.1 pg/mL Li et al. (2013)  
Fig. 9. Schematic comparison between of convention synthetic pathway and MCR strategy. Reproduced with permission from ref. (Alvim et al., 2014). Copyright 
(2014) Royal Society of Chemistry. 
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MCR (Vrbová and Marek, 1990). In this approach, the prepared 
biosensor was investigated for the detection of D-galactose in real sam-
ples of plasma and serum from patients with suspected galactosemia. In 
2018, Lowe et al. described an efficient route for the development of a 
holographic sensor modified with Ugi-4MCR ligands for cocaine deter-
mination using a smart-phone based device (Oliveira et al., 2018). 
Several ligands were prepared to perform protein− cocaine binding, 
especially human carboxylesterase-1 and the catalytic monoclonal 
antibody GNL7A1. The Ugi-4CR reaction involved β-alanine, γ-amino-
butyric acid, and cyclohexyl isocyanide below the surface of a hybrid 
hydrogel of poly(2-hydroxyethyl-methacrylate− co-ethylene 
dimethacrylate-co-methacrolein) as the carbonyl source. The efficiency 
of the MCR platform for the rapid detection of cocaine in the same range 
as clinical drug samples was demonstrated (Fig. 10). 
Based on the above-mentioned data, MCRs could be used as versatile 
and flexible synthetic tools to design an effective biosensor for the rapid 
detection of COVID-19. On account of the fact that MCRs are able to 
incorporate several different bioreceptors within a single platform, this 
approach could produce a highly sensitive and rapid optical biosensor. 
5.2. Computational methods 
In recent years, various computational approaches have been 
employed in drug discovery and biosensor development. These encom-
pass QSAR, virtual screening, molecular docking, homology modelling, 
and machine learning approaches (Gonzalez-Navarro et al., 2016; Green 
et al., 2019). Some of these methods have their own advantages and 
drawbacks. Docking simulations can pinpoint and optimize the 3D 
structure of small molecules as well as identify potential binding sites. 
However, the docking simulation process is somewhat tedious, partic-
ularly for macromolecular compounds (Bagherian et al., 2020). Methods 
which employ data from more computationally rigorous, and physically 
accurate calculations, such as molecular dynamics simulations (MD), are 
limited in applicability due to their computational cost and poor accu-
racy (Ellingson et al., 2020). Machine learning techniques have revo-
lutionized the use of computational methods in systems biology. 
Machine learning can accurately analyze the correlation between 
chemical structure and interactions with known proteins to form ligand 
pairs, to provide statistical models to predict the activity of other un-
known compounds. The prediction of binding energy requires a 
regression algorithm, and predicting the likelihood of an interaction 
could be achieved (Kundu et al., 2018). In addition, a statistical learning 
approach has very recently been applied for the classification of 
G-protein coupled receptors and DNA-binding proteins. This approach 
has been used with several protein structures to predict interactions, 
including protein–protein interactions (Bock and Gough, 2001), fold 
recognition (Dubchak et al., 1995), and also structural predictions (Cai 
et al., 2002). 
In order to discover new bioreceptors which might bind to specific 
targets in the COVID-19 virus, a machine learning approach could 
provide a more reliable and rapid solution. 
6. Conclusions and future directions 
The rapid and sensitive detection of pandemic COVID-19 virus, could 
be the key to limit the transmission throughout the world. Various 
diagnostic techniques have already been developed for detecting 
COVID-19, and some have even been commercialized. However, the 
most important point to consider for diagnosis in different countries, is 
to develop techniques that are inexpensive, simple and user-friendly. It 
is important to reduce the cost of diagnosis to produce the best result in 
the shortest possible time, as well as to reduce the need for travel to 
hospitals or clinics by developing POC systems. One important example 
that has not so far received much attention, concerns the plasmonic and 
optical properties of nanomaterials, such as AuNPs which could be 
incorporated into face-masks or PPE in the form of nanotechnology- 
enabled functional clothing. In the presence of SARS-CoV-2, the color 
of the NPs could significantly change, to allow quick and easy virus 
detection and prevent the further spread of the virus. 
Given the widespread prevalence of COVID-19 worldwide and the 
increasing mortality, early and highly accurate detection of suspected or 
infected individuals can play an important role in reducing mortality 
and preventing other people from becoming infected. Various studies by 
researchers around the world have led to the development of diagnostic 
systems based on optical nanosensors, with an emphasis on the devel-
opment of POC devices. New creative ideas can lead to more innovative 
approaches, which could significantly reduce the prevalence and mor-
tality of this pandemic disease. 
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